• Home
  • About
  • Contact Us and Contribute
  • Terms of Use
  • AAPS

AAPS Blog

~ Share. Engage. Impact Pharmaceutical Sciences.

Author Archives: AAPS Blog

APOC3: A Promising Target for New Cardiovascular Drugs

16 Wednesday Aug 2017

Posted by AAPS Blog in Current Perspectives

≈ Leave a comment

Tags

antisense therapy, APOC3, cardiovascular disease, David Warmflash, Isis Pharmaceuticals, pancreatitis

By David Warmflash

Our society, and to some extent even clinical medicine, is focused on blood lipoproteins, especially low density lipoprotein (LDL, the “bad” cholesterol). LDL is at center stage for assessment of one’s risk, and also as a blood value to modify with drugs, such as statins, and dietary change. There are good reasons for this, but another serum value, triglycerides, also plays a key role, yet how many people are aware of their “trig” level? Continue reading →

Tocols are Too Cool!

10 Thursday Aug 2017

Posted by AAPS Blog in Current Perspectives

≈ Leave a comment

Tags

radioactive, tocols, Ujwani Nukala, vitamin E

By Ujwani Nukala

There is an urgent need for compounds that can be used to protect people in case of accidental or terrorist initiated radiological emergencies. Developing compounds that are effective, nontoxic, inexpensive, easy to administer, and capable of being stored for rapid distribution among victims of radiological accidents or attacks, is a pressing but daunting endeavor. In this regard, vitamin E may be the answer. As a well-known antioxidant, vitamin E is effective in scavenging free radicals generated by radiation exposure. Continue reading →

Can Good Scientists Make Good Leaders?

08 Tuesday Aug 2017

Posted by AAPS Blog in Careers

≈ Leave a comment

Tags

career, Collaboration, leadership, Padmanabhan Eangoor, pharmaceutical scientist, professional development, Soft Skills, success, visionary

By Padmanabhan (Paddy) Eangoor

Some people are born to be leaders while some are trained to become leaders. Scientists, on the other hand, are born for science but trained to become better scientists. When we picture a leader, it would most likely not be a scientist. That may be because most of us think that these two tracks don’t connect well. Some of us wonder, “Can good scientists make good leaders?” Continue reading →

NIH Next Generation Initiative Plan for Rescuing Biomedical Research

03 Thursday Aug 2017

Posted by AAPS Blog in Current Perspectives

≈ Leave a comment

Tags

grants, Vivek Agrahari, young scientists

By Vivek Agrahari

The National Institutes of Health (NIH) is the most important funding source for biomedical research in the U.S. In an effort to provide funding support for young (early- and mid-career) scientists, the NIH proposed on May 2, 2017 the Grant Support Index (GSI) to increase funding through a point system that caps individual primary investigators at three R01 research grants. The initiative is called upon to stabilize the next generation of researchers and generate about 2,000 more grants over the next five years. This is intended to balance the grant distribution and harness a greater diversity of creative ideas. Continue reading →

Rethinking Halogen Bonds

01 Tuesday Aug 2017

Posted by AAPS Blog in APQ Section

≈ Leave a comment

Tags

Andy Coop, drug design, halogen bond, hydrogen bond, natural products

By Andy Coop

Halogens (such as fluorine, chlorine, bromine) are a key component of many natural products, especially marine natural products, but have been widely utilized in the design of drugs. The reason is the unique properties of halogens, such as fluorine replacing hydrogen on aromatics rings, as they share a similar size, yet the halogen will prevent metabolism (through hydroxylation) of the aromatic ring. Also,  the addition of halogens increases lipophilicity, thus transport across lipid membranes, and their electronic properties alters the electronic properties of the drug molecule. All these properties are widely utilized in drug optimization, and the utilization of halogens to mimic functional groups able to participate in hydrogen bonds with the biological target seems an obvious extension but, surprisingly, is more complicated than first appears. Continue reading →

← Older posts
Newer posts →

Enter your email address to follow this blog and receive notifications of new posts by email.

Categories

  • AAPS Events
  • AAPS Foundation
  • AAPS Publications
  • AAPS Students
  • AAPS Webinars
  • APQ Section
  • Back to School Week
  • Bioequivalence Focus Group
  • Biosimilars Focus Group
  • BIOTEC Section
  • Breaking Pharmaceutical News
  • Careers
  • CMC Statistics Focus Group
  • CPTR Section
  • CRO Focus Group
  • Current Events
  • Current Perspectives
  • DCS Focus Group
  • DDDI Section
  • Drug Metabolism Focus Group
  • eLearning
  • Excipients Focus Group
  • FDD Section
  • Formulation Development
  • General
  • Generic Pharmaceuticals Focus Group
  • Ligand Binding Assay Bioanalytical Focus Group
  • MSE Section
  • Pharmacometrics Focus Group
  • PharmSci Roundup
  • PPB Section
  • PPDM Section
  • Process Development Focus Group
  • Quick Perspective
  • Reader's Choice
  • RS Section
  • Stability Focus Group
  • Sterile Products Focus Group
  • TDDP Focus Group

Tags

2012 AAPS Annual Meeting and Exposition 2013 AAPS Annual Meeting and Exposition 2014 AAPS Annual Meeting 2015 AAPS Annual Meeting and Exposition 2015 AAPS National Biotechnology Conference 2016 NBC AAPS 2016 AAPS Foundation AAPS Newsmagazine biologics biosimilars biotechnology cancer David Warmflash drug delivery Drug Development Ebola education FDA Formulation marijuana Megan Cooley Publishing Rakesh Gollen regulatory science research Robert G. Bell The AAPS Journal Vaccines Zika virus

Resources

  • AAPS Blog Committee
  • Human and Veterinary Therapeutics

RSS Feed

  • RSS - Posts
  • RSS - Comments

Blog at WordPress.com.

Cancel